Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Neutra Corp (PK:NTRR)

Business Focus: Pharmaceuticals

Get the company report for the most recent outlook updated daily

Insider Chart - Past 6 Months

Insider Filings

Latest 10 SEC Form 4 filings for NTRR*US within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Dec 29, 2023 17:54 ET
Neutra Reflects on 2023 and Looks Forward to 2024
via NewMediaWire -- Neutra Corporation (OTC PINK:NTRR), an emerging health and wellness research and development company, reflects on the 2023 year and plans for moving forward in 2024. In the previous press release, Neutra announced a medium-term...
Read full article
Oct 30, 2023 10:08 ET
Neutra Announces Strategic and Financial Value Creation Plan
via NewMediaWire - Neutra Corporation (OTC PINK: NTRR), an emerging health and wellness research and development company, announces today a two-year, medium-term management plan in order to meet the rapidly increasing demand for the company's...
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
3.13
--
--
Price to Sales - TTM
50.31
2.45
3.32
Price to Book - most recent quarter
--
1.91
2.21
Price to Cash Flow per share - TTM
--
12.81
14.62
Price to Free Cash Flow per share - TTM
--
19.04
24.76
See all valuations

Business Summary

Sector:  Healthcare Industry:  Pharmaceuticals

Neutra Corp. is an early-stage research and development company. The Company is engaged in marketing and participating in the nutraceutical space by bringing products derived from all natural and organic origins. The Company plans to research and bring new technology to the Nutraceutical space. The Company is primarily focused on participating in the medical cannabis market, which is a nutraceutical sub-market. It intends to entrust the manufacturing to a nutraceutical contractor to private label all of its products and to sell them under its brand. It primarily sells hemp-derived products, including products containing delta-8-THC and other cannabinoids. Its subsidiaries include Diamond Anvil Designs, LLC, Deity Corporation and Vivis Corporation.

See business summary

 

Twitter

Search (past week) for $NTRR

  • No tweets found